Aslan Fred — SEC Form 4 filings
SEC reporting owner CIK 1909362. 13 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-07-22 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 7 filings — 172,995 shares, $1,453,614 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 61,888 shares @ $11.16 ($690,392) in Artiva Biotherapeutics, Inc., filed 2026-09-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | Chief Executive Officer, Director | 13 | — | 7 legs · 172,995 sh · $1,453,614 | 19 |
Form 4 filings — Aslan Fred
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/award (A): 110,000 @ $0 · Grant/award (A): 315,000 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/award (A): 45,000 @ $0 · Grant/award (A): 155,000 (derivative) @ $0 | EDGAR |
| 2026-09-09 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Sale (S): 23,429 @ $10.92 | EDGAR |
| 2026-09-04 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Sale (S): 61,888 @ $11.16 | EDGAR |
| 2026-05-19 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Sale (S): 27,116 @ $9.01 | EDGAR |
| 2026-02-18 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/award (A): 366,850 @ $0 · Tax withholding (F): 14,600 @ $4 | EDGAR |
| 2025-12-15 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Sale (S): 3,187 @ $6 | EDGAR |
| 2025-12-12 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/award (A): 869,136 @ $0 · Disposition to issuer (D): 100,577 (derivative) · Disposition to issuer (D): 51,463 (derivative) · Disposition to issuer (D): 257,319 (derivative) · Disposition to issuer (D): 26,450 (derivative) · Disposition to issuer (D): 113,999 (derivative) · +1 more | EDGAR |
| 2025-11-17 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Tax withholding (F): 6,347 @ $3.25 · Sale (S): 6,375 @ $3.38 | EDGAR |
| 2025-10-17 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Sale (S): 25,500 @ $6 | EDGAR |
| 2025-08-18 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Tax withholding (F): 4,472 @ $2.13 · Sale (S): 25,500 @ $2.73 · Tax withholding (F): 4,472 @ $2.75 | EDGAR |
| 2025-03-07 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/award (A): 200,000 @ $0 | EDGAR |
| 2024-07-22 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/award (A): 228,905 @ $0 · Grant/award (A): 343,811 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1909362 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →